Home/Filings/4/0000899243-22-004144
4//SEC Filing

Katz Richard D 4

Accession 0000899243-22-004144

CIK 0001624658other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:15 PM ET

Size

5.9 KB

Accession

0000899243-22-004144

Insider Transaction Report

Form 4
Period: 2022-02-01
Katz Richard D
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-02-01+255,000255,000 total
    Common Stock (255,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units were granted pursuant to a retention plan approved by the board of directors of the Issuer.
  • [F2]The restricted stock units will vest ratably in equal installments on July 15th and January 15th of each year over the three-year period immediately following February 1, 2022, and will accelerate in full upon the consummation of a change in control, in each case, subject to the Reporting Person's continued service through each applicable vesting date.

Issuer

Allena Pharmaceuticals, Inc.

CIK 0001624658

Entity typeother

Related Parties

1
  • filerCIK 0001293577

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:15 PM ET
Size
5.9 KB